 |
humanized immunoglobulin G1 (IgG1) T-cell bispecific (TCB) antibody targeting carcinoembryonic antigen (CEA) and CD3 epsilon chain (CD3e) on T-cells |
|---|---|
| Trade Name | |
| Orphan Indication | Pancreatic Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2017-07-27 00:00:00 |
| Sponsor | Genentech, Inc.;1 DNA Way, MS 35-5E;South San Francisco, California, 94080 |
